SoftOx Solutions is trading at NOK 0.12, up 6.11%, after rebounding from the prior session’s sharp decline; no confirmed explanation for the rebound was identified.
- Its September 23 half-year report showed a NOK 13.6 million loss and cash of NOK 21.4 million.
- Analyst Group highlighted ongoing clinical progress and funding into the first-half 2027 readout.
- No new September 24 catalyst was identified.